LOC105372194: A Protein involved in various cellular processes and diseases
LOC105372194: A Protein involved in various cellular processes and diseases
LOC105372194 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of evolutionarily conserved transmembrane protein (SMTP) family, which includes proteins that are involved in various signaling pathways, including intracellular signaling, cell signaling, and tissue signaling.
LOC105372194 is characterized by its unique structure and biology. It has a molecular weight of approximately 180 kDa and consists of a 156 amino acid chain. LOC105372194 is predominantly localized to the endoplasmic reticulum (ER) and cytoplasm of cells, and is also found in the secretory pathway endosomal system (ES) and the endoplasmic reticulum (ER).
LOC105372194 is involved in various cellular processes, including cell signaling, cell division, and tissue repair. It is a positive regulator of the protein kinase B-complex, which is involved in cell signaling, and it is a negative regulator of the transcription factor p53. LOC105372194 has been shown to play a role in the regulation of cell growth, differentiation, and survival.
LOC105372194 has also been shown to be involved in the development and progression of various diseases, including cancer. For example, LOC105372194 has been shown to be overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This overexpression is associated with poor prognosis and increased risk of disease.
LOC105372194 is also a potential drug target in cancer treatment. For example, LOC105372194 has been shown to be a good candidate for anti-cancer drug development due to its unique structure and biology. LOC105372194 has been shown to be highly sensitive to small molecules, such as inhibitors, which have been shown to suppress its activity.
In addition to its potential as a drug target, LOC105372194 also has potential as a biomarker for cancer diagnosis and treatment. For example, LOC105372194 has been shown to be upregulated in various types of cancer, including breast, ovarian, and prostate cancer. This upregulation is associated with poor prognosis and increased risk of disease.
LOC105372194 has also been shown to be downregulated in various types of cancer, including breast, ovarian, and prostate cancer. This downregulation is associated with improved prognosis and reduced risk of disease. Therefore, LOC105372194 may be a useful biomarker for cancer diagnosis and treatment.
In conclusion, LOC105372194 is a protein that is involved in various cellular processes, including cell signaling, cell division, and tissue repair. It is a positive regulator of the protein kinase B-complex and a negative regulator of the transcription factor p53. LOC105372194 has been shown to play a role in the regulation of cell growth, differentiation, and survival, and it is involved in the development and progression of various diseases, including cancer.
LOC105372194 is also a potential drug target and biomarker for cancer treatment. Its unique structure and biology make it a promising candidate for anti-cancer drug development, and its sensitivity to small molecules makes it a good candidate for biomarker development. Further research is needed to fully understand the role of LOC105372194 in cancer biology and its potential as a drug
Protein Name: Uncharacterized LOC105372194
The "LOC105372194 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372194 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422
